Androgenetic Alopecia: An Evidence-Based Treatment Update

@article{Varothai2014AndrogeneticAA,
  title={Androgenetic Alopecia: An Evidence-Based Treatment Update},
  author={S. Varothai and W. Bergfeld},
  journal={American Journal of Clinical Dermatology},
  year={2014},
  volume={15},
  pages={217-230}
}
  • S. Varothai, W. Bergfeld
  • Published 2014
  • Medicine
  • American Journal of Clinical Dermatology
  • BackgroundAndrogenetic alopecia (AGA) is one of the most common chronic problems seen by dermatologists worldwide. [...] Key Method MEDLINE, EMBASE and Cochrane Library were searched for systematic reviews, randomized controlled trials, open studies, case reports and relevant studies of the treatment of male and female AGA. The relevant articles were classified according to grade and level of evidence.ResultsThe medical treatments with the best level of evidence classification for efficacy and safety for male…Expand Abstract

    Paper Mentions

    OBSERVATIONAL CLINICAL TRIAL
    assess the literature on PRP outcomes for AGA, with a focus on specific clinical outcomes in a comparative view, in accordance with PRISMA statement for reporting this meta-analysis  
    ConditionsAndrogenetic Alopecia
    OBSERVATIONAL CLINICAL TRIAL
    Androgenetic alopecia is a common form of diffuse hair loss in both men and women,It primarily affects the top and front of the scalp with different clinical presentations and… Expand
    ConditionsAlopecia, Androgenetic
    InterventionDiagnostic Test

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 120 REFERENCES
    PATTERNED LOSS OF HAIR IN MAN: TYPES AND INCIDENCE
    • 663
    Male androgenetic alopecia
    • 121
    • PDF
    Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia.
    • 214
    Effective treatment of female androgenic alopecia with dutasteride.
    • 92
    Evidence‐based (S3) guideline for the treatment of androgenetic alopecia in women and in men
    • 153
    • Highly Influential
    Treatment of hyperandrogenic alopecia in women.
    • 85